Digoxin ToxicityEvaluation in Clinical Practice with Pharmacokinetic Correlations

被引:0
作者
Karine Lecointre
Laurence Pisanté
Francis Fauvelle
Serge Mazouz
机构
[1] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service Pharmacie
[2] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service de Cardiologie
来源
Clinical Drug Investigation | 2001年 / 21卷
关键词
Root Mean Square Error; Digoxin; Total Clearance; Digoxin Concentration; Serum Digoxin Concentration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:225 / 232
页数:7
相关论文
共 50 条
[41]   Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine [J].
Susanne Johansson ;
Jessica Read ;
Stuart Oliver ;
Mark Steinberg ;
Yan Li ;
Eleanor Lisbon ;
David Mathews ;
Philip T. Leese ;
Paul Martin .
Clinical Pharmacokinetics, 2014, 53 :837-847
[42]   Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers [J].
Friedrich, C. ;
Ring, A. ;
Brand, T. ;
Sennewald, R. ;
Graefe-Mody, E. U. ;
Woerle, H. -J. .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 36 (01) :17-24
[43]   Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers [J].
C. Friedrich ;
A. Ring ;
T. Brand ;
R. Sennewald ;
E. U. Graefe-Mody ;
H.-J. Woerle .
European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 :17-24
[44]   Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects [J].
Trivedi, Ashit ;
Sohn, Winnie ;
Hsu, Cheng-Pang ;
Jafarinasabian, Pegah ;
Zhang, Hanze ;
Hutton, Shauna ;
Flach, Stephen ;
Abbasi, Siddique ;
Dutta, Sandeep ;
Lee, Edward .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (03) :388-396
[45]   Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers [J].
Harder, S ;
Thurmann, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (05) :475-480
[46]   A Two-Compartment Population Pharmacokinetic-Pharmacodynamic Model of Digoxin in Adults, With Implications for Dosage [J].
Jelliffe, Roger W. ;
Milman, Mark ;
Schumitzky, Alan ;
Bayard, David ;
Van Guilder, Michael .
THERAPEUTIC DRUG MONITORING, 2014, 36 (03) :387-393
[47]   Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers [J].
H. M. Faessel ;
A. H. Burstein ;
M. D. Troutman ;
S. A. Willavize ;
K. D. Rohrbacher ;
D. J. Clark .
European Journal of Clinical Pharmacology, 2008, 64 :1101-1109
[48]   Inotropic Effect of Digoxin in Humans: Mechanistic Pharmacokinetic/Pharmacodynamic Model Based on Slow Receptor Binding [J].
Michael Weiss ;
Wonku Kang .
Pharmaceutical Research, 2004, 21 :231-236
[49]   Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers [J].
Aiba, T ;
Ishida, K ;
Yoshinaga, M ;
Okuno, M ;
Hashimoto, Y .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (01) :114-119
[50]   Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers [J].
Faessel, H. M. ;
Burstein, A. H. ;
Troutman, M. D. ;
Willavize, S. A. ;
Rohrbacher, K. D. ;
Clark, D. J. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (11) :1101-1109